argenx
The Early Development Global Regulatory Lead will serve as a key strategic advisor and facilitator for regulatory activities within the global Early Development regulatory team, supporting the rapid growth of the company's early-stage pipeline. This role involves developing sound global regulatory strategies, ensuring patient-centricity, and providing timely guidance to support early asset progression through clinical development. The position requires close collaboration with cross-functional partners to ensure robust regulatory foundations and smooth transitions into later-stage development.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2008
Reaching Patients Through Immunology Innovation
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for argenx.
argenx didn’t post a salary, so this is our estimate from similar listings.
15% below the average for this role
OMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Early Development Global Regulatory Lead
ICON plc
Manager, Regulatory Affairs
Deciphera Pharmaceuticals
Senior Manager, Global Regulatory Strategy
Telix Pharmaceuticals
Senior Director, Regulatory Strategy – Global Regulatory Lead
Beeline Medicines
Manager, Regulatory Affairs
Deciphera Pharmaceuticals
Director, Global Regulatory Affairs
Zenas BioPharma